These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 28242263)

  • 1. Prolonged cannabis withdrawal in young adults with lifetime psychiatric illness.
    Schuster RM; Fontaine M; Nip E; Zhang H; Hanly A; Evins AE
    Prev Med; 2017 Nov; 104():40-45. PubMed ID: 28242263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Withdrawal, Mood, and Sleep Inventories After Monitored 3-Week Abstinence in Cannabis-Using Adolescents and Young Adults.
    Sullivan RM; Wallace AL; Stinson EA; Montoto KV; Kaiver CM; Wade NE; Lisdahl KM
    Cannabis Cannabinoid Res; 2022 Oct; 7(5):690-699. PubMed ID: 34678051
    [No Abstract]   [Full Text] [Related]  

  • 3. Prospective assessment of cannabis withdrawal in adolescents with cannabis dependence: a pilot study.
    Milin R; Manion I; Dare G; Walker S
    J Am Acad Child Adolesc Psychiatry; 2008 Feb; 47(2):174-179. PubMed ID: 18176332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification (Part II): Psychiatric complaints and their relation to delta-9-tetrahydrocannabinol and its metabolites in serum.
    Bonnet U; Borda T; Scherbaum N; Specka M
    Drug Alcohol Depend; 2015 Oct; 155():302-6. PubMed ID: 26298553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Which psychiatric comorbidities in cannabis dependence during adolescence? Comparison of outpatients and controls].
    Dorard G; Bungener C; Phan O; Edel Y; Corcos M; Berthoz S
    Encephale; 2018 Feb; 44(1):2-8. PubMed ID: 27637871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Motivations for cannabis cessation, coping and adaptation strategies, and perceived benefits: impact on cannabis use relapse and abstinence].
    Chauchard E; Septfons A; Chabrol H
    Encephale; 2013 Dec; 39(6):385-92. PubMed ID: 23928064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis withdrawal severity and short-term course among cannabis-dependent adolescent and young adult inpatients.
    Preuss UW; Watzke AB; Zimmermann J; Wong JW; Schmidt CO
    Drug Alcohol Depend; 2010 Jan; 106(2-3):133-41. PubMed ID: 19783382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis withdrawal in patients with and without opioid dependence.
    Chauchard E; Goncharov O; Krupitsky E; Gorelick DA
    Subst Abus; 2014; 35(3):230-4. PubMed ID: 24745656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in cigarette and alcohol use during cannabis abstinence.
    Allsop DJ; Dunlop AJ; Saddler C; Rivas GR; McGregor IS; Copeland J
    Drug Alcohol Depend; 2014 May; 138():54-60. PubMed ID: 24613633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying the clinical significance of cannabis withdrawal.
    Allsop DJ; Copeland J; Norberg MM; Fu S; Molnar A; Lewis J; Budney AJ
    PLoS One; 2012; 7(9):e44864. PubMed ID: 23049760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withdrawal symptoms do not predict relapse among subjects treated for cannabis dependence.
    Arendt M; Rosenberg R; Foldager L; Sher L; Munk-Jørgensen P
    Am J Addict; 2007; 16(6):461-7. PubMed ID: 18058411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis withdrawal is common among treatment-seeking adolescents with cannabis dependence and major depression, and is associated with rapid relapse to dependence.
    Cornelius JR; Chung T; Martin C; Wood DS; Clark DB
    Addict Behav; 2008 Nov; 33(11):1500-1505. PubMed ID: 18313860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comorbidity in 207 cannabis users in a specific outpatient setting].
    Guillem E; Arbabzadeh-Bouchez S; Vorspan F; Bellivier F
    Encephale; 2015 Jun; 41 Suppl 1():S7-12. PubMed ID: 25123065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of extended cannabis abstinence on clinical symptoms in cannabis dependent schizophrenia patients versus non-psychiatric controls.
    Rabin RA; Kozak K; Zakzanis KK; Remington G; George TP
    Schizophr Res; 2018 Apr; 194():55-61. PubMed ID: 28285022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis withdrawal in chronic, frequent cannabis smokers during sustained abstinence within a closed residential environment.
    Lee D; Schroeder JR; Karschner EL; Goodwin RS; Hirvonen J; Gorelick DA; Huestis MA
    Am J Addict; 2014; 23(3):234-42. PubMed ID: 24724880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in tobacco consumption in cannabis dependent patients with schizophrenia versus non-psychiatric controls during 28-days of cannabis abstinence.
    Rabin RA; Dermody SS; George TP
    Drug Alcohol Depend; 2018 Apr; 185():181-188. PubMed ID: 29459327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium carbonate in the management of cannabis withdrawal in humans: an open-label study.
    Winstock AR; Lea T; Copeland J
    J Psychopharmacol; 2009 Jan; 23(1):84-93. PubMed ID: 18515451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabis withdrawal in the United States: results from NESARC.
    Hasin DS; Keyes KM; Alderson D; Wang S; Aharonovich E; Grant BF
    J Clin Psychiatry; 2008 Sep; 69(9):1354-63. PubMed ID: 19012815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis Withdrawal in Adults With Attention-Deficit/Hyperactivity Disorder.
    Chauchard E; Hartwell KJ; McRae-Clark AL; Sherman BJ; Gorelick DA
    Prim Care Companion CNS Disord; 2018 Feb; 20(1):. PubMed ID: 29489073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic criteria for cannabis withdrawal syndrome.
    Gorelick DA; Levin KH; Copersino ML; Heishman SJ; Liu F; Boggs DL; Kelly DL
    Drug Alcohol Depend; 2012 Jun; 123(1-3):141-7. PubMed ID: 22153944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.